Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

12th World AIDS Conference

multifocal * Nairobi 127

-Keyword

Abstract --

Keyword

Abstract -+

HAART for progressive leucoencephalopathy (PML) in
apy using packageable multimeric ribozymes/Anti-HIV-1 gene th
U Concerted Action on Multinational AIDS Scenarios/HIV scree
U Concerted Action on AIDS Scenarios/Estimated: Isoniazid vs. rifabutin/ study for the preventive ther
nts harbouring both the multinucleoside analogue resistance mut
on HIV/STD risk/NIMH multisite trial: Social cognitive mediators o
ion intervention/NIMH HIV prevention trial: A randomize
erapies: Results from a interview project/Adherence to c
herapy: Results from a interview project/Predictors for n
eduction intervention: A comparison/The cost of deliverin
HIV? Results from a US sample/Are high-frequency amp
ing approach/Effect of multitherapies on health status and hospit
ai/HIV seropositivity in multitransfused thalassemics and blood
rimary HIV-1 isolates/ Multitropism of primary HIV-1 isolates/
mission of HIV - Using multivariate methods in reanalyzing previ
ogramme in suburbs of Mumbai /Reduction in refusal to admit HIV
he Hijda community in Metro and its implications/Taxon
mmercial sex workers in Metro's redlight area/A compreh
s/Male STD patients in, India, are in urgent need of cultur
ability to HIV infection in, India/Adolescent sexuality and v
among college youth in /Risk taking sexual behaviour in t
DS clinic G.T. Hospital,, India/Compliance of tuberculosi
roviral (ARV) therapy in /Efficacy of antiretroviral (ARV) th
HIV/AIDS individuals in, India/Scenario of anti-retroviral t
ring "window period" in /HIV seropositivity in multitransfu
tes where MSM meet in Metro/Sex mapping of sites wher
d leads to plateauing in /Sex worker intervention project b
ural history of HIV-1/2 in, India/The natural history of HIVand HIV transmission in (Bombay), India/Risk factors ass
axis for TB in HIV/AIDS, /Chemoprophylaxis for TB in HIV/
ban slum population of megapolis, review of a decade/E
safe immunomodulator murabutide /Inhibition of HIV-1 replication
ation analysis using the Murex-lnnogenetics Lipa HIV-1 RT assay
/M, HIV-1/O and HIV-2/ Murex HIV-1.2.0 is a highly sensitive and s
HIV-2 infections/Use of HIV recombinant and anti-HIV-2 as
nhibitors (RRIs) in the murine model of immunodeficiency diseas
ase of polygamy in the muslim community in Uganda/The dilem
rhesus monkeys with a mutant SHIV by systemic or mucosal inoc
hild transmission of Pol T215Y HIV-1 isolates related to a h
recore hepatitis B virus infection with lamivudine-containin
nhibitor treatment or by mutants in the viral protease/Transmissio
al?/Fitness of HIV-1 RT: Is MOller's ratchet operational?/
cy of CKR5-gene allele in Mexican population: Its relation
STI/HIV transmission in Mutare, Zimbabwe/Peer education to red
g combination therapy/ Mutation pattern of the RT and protease g
etion and CCR-5 M303 mutation in South African populations/Th

60963
41247
43134
43488
60858
32296
14267
14273
392*/32326
413*/42282

60215
60254
24133
23263
60684
33142
12425
13430
13491
14209
14321
14331
22151
22399
22406
23263
43288
43483
60331
60457
60907
60937
22424
41225
41106
42121
12356
14245
11244
23308
32118
11132
11157
13331

-island communities in Mwanza region, Tanzania/Geographical v
case-control study in,Tanzania/Risk factors for seroco
f STDs: Or... what after,Masaka and Rakai?/The future o
t the intervention of the trial: How many patients with an S
t social phenomenon in,Tanzania/AIDS stigma: A persist
ed 15-19 years in rural region, Tanzania: A random sam
haviour: A case study of Mwingi and Homa Bay, Kenya/Social-cult
nd condom use among MWM in Brazil/Changes in sexual behavio
racterization of HIV-1 in Myanmar (Burma)/Genetic and serologic
astal towns of southern /Identifying HIV risk factors and i
n Eastern Shan State, /Community participation in the
HIV/AIDS prevention in (Burma)/Strategies for change:
IV/AIDS epidemic in /The expansion of HIV safe bloo
ring countries Thailand/ /Prevention and care for migrant
mong migrant workers in /Prevention of HIV/AIDS among
tional AIDS Program in /Partnership building: The role of
quired bacteremia and mycobacteremia in febrile adults admitted
egulation/The effect of mycobacteria on enhancement of HIV rep
ent of non-tuberculous (NTM) in HIV disease/Lipo
nts/Infection by atypical (AM) in HIV-1+ patients/Inf
enegal/Comparison of growth indicator tube and L
es on clinical approach/ Mycobacterial species distribution in isola
ents with HIV infection/ nucleic acids in tissues of p
ion in Lusaka, Zambia/ blood cultures to detect dis
e antiretroviral therapy/ lymphadenitis associated
or tuberculosis/Risk of mycobacterial disease in patients with ad
Decreasing incidence of diseases in HIV+ patients/
ART)/Manifestation of infection after initiating of hi
epressed responses to antigens in HIV patients re
r immune responses to antigens observed in pulm
inical manifestations of enteric infection in patients
988-1997/Incidence of infections among HIV posit

13119
13282
24176
33234
417*/34159
60682
14211
33548
13130
14197
14232
33433
42119
42427
43259
44252
22109
21145
22170
31210
41169
22157
41157
60311
60505
22145
22166
22172
31175
31206
32110
60859

s chemokine receptor 5
he CCR5A32 deletion
e analogue resistance
e multidrug resistance
C combination/M184V
TC-associated M184V
ns of the LiPA HIV-1 RT
Semi-quantitative HIV-1
with a ZDV-resistance
d-type virus infectivity/
me of primary infection/
us didanosine therapy/
n/Compensatory point
o/Brazil/Prevalence of
ssociated resistance
nce of HIV-1 resistance
currence of CTL escape
r therapy/Pre-existent
215Y/F carry these two
e-associated genotypic
dy)/Resistance related
al therapy/Detection of
o detect AZT-resistant
f protease resistance
PA) for the detection of
omparison of protease
detection of resistance
mpact of protease gene
frequency of genotypic
pe and resistance point
1997)/Drug resistance
ients/Natural protease

on response to antiretroviral ther
on disease progression in HIV inf
Q151M and the AZT resistance
Q151M/L and the AZT resistanc
is not predictive of therapeutic fai
in reverse transcriptase (RT) sho
detection assay/Novel clinical a
analysis using the Murex-lnnoge
at codon 215, in different proporti
Mutations in the leucine zipper-like heptad
conferring resistance to protea
conferring resistance to zidovu
mutations in the HIV gag region that are di
that confer resistance to RT inhi
/Viral load reduction after chan
in a US military cohort of antiret
in HIV-1 infection/Rare occurre
of the HIV protease gene were
on different HIV-1 quasi-specie
in plasma HIV of patients failing
in HIV-1 pol gene of patients tre
in the HIV-1 reverse transcripta
/Genotyping HIV-1 reverse tran
in therapy-naive HIV-1 positive
in the RT gene of HIV-1/A corn
in HIV-1 genomes detected in p
in HIV-1 RT/Line Probe assay
on virological response to nelfin
associated with resistance to A
against antiretroviral drugs in s
in HIV-1 strains from treatmentobserved in HIV infected Japan

533*/33516
12257
11122
12116
13304
32296
32300
32310
41214
41223
41225
42200
11121
12201
32306
378*/11126
11168
12342
13215
31125
32294
32296
32301
32302
32311
41143
41208
41216
41217
41219
41222
42197
42198
42199
60444
60296

urope in incidence of Mycobacterium tuberculosis infections a 22127
ent/Potential source of bovis infection and risk of 22143, Brazil/Drug-resistant tuberculosis (MTB) in a g 22163
primary prophylaxis for avium complex (MAC) in 22167
ART era/Disseminated avium complex infection i 22168
obial susceptibilities for avium complex (MAC) iso 22169
)/Skin test reactivity to avium sensitin (MAS) in 22171
n HIV-infected children/ avium intracellulare com 22174
nfected with HIV-1 and tuberculosis is associate 31167
I infection with HIV and tuberculosis/Cell surface 31184
ents with symptomatic avium complex (MAC) inf 32324
say (LCR)/Diagnosis of tuberculosis using lygase 41162
ium for the recovery of tuberculosis from clinical 41169
tic view/Disseminated avium complex (MAC) inf 43481
eness of prophylaxis for avium complex in AIDS/ 479*/44238
mination of HIV-related avium complex infection-i 60170
mannan extracted from tuberculosis/Regulation 60313
lar evidence for a novel causing disseminated inf 60412
from recently acquired tuberculosis infection in a 60415
ulosis/Transmission of tuberculosis between HI 60544
ative coccobacillis and tuberculosis in a patient i 60605
s: Report of four cases/ xenopi infection in HIV pa 60696
n mononuclear cells by mycobacterium tuberculosis during activ 21189
ged fever/Prediction of tuberculosis infection in 22138
gical evaluation/Active tuberculosis infection in 22148
ocytes associated with bovis BCG-induced dise 31169
associated with genital mycoplasma and streptococci species is 60882
gical study of superficial mycoses in AIDS patients in Yaounde/Cli 31218
esenting as transverse myelitis in an HIV patient/Plasma cell gra 60176
etection of HIV in the myocardial cells in a large population of HI 60434
revention: The project " Necessaire "/Towards a better integration 13569
ong college students in N'Djamena, Chad/Sexual behavior, knowl 23437
m (VF) of nonoxynol-9 ( N-9 ) in women at low risk of sexually trans 33138
fic neutralizing activity ( NA ) of HIV infected patients receiving antir 31108
h HIV/AIDS in Uganda ( NACWOLA)/Formed groups among HIV p 33598
al practitioners in Tamil Nadu, South India/Impact of training in sex 13475
d Thiruchengode, Tamil, India/Research on sex and sexualit 14123
groups in Salem, Tamil,India/HIV/AIDS awareness and inte 33250
10 cities/towns of Tamil /Male sexual health programme for 60821
itted diseases (STD) in Nairobi-Kenya /Partner notification by die 14306
HIV-1 infected adults in Nairobi, Kenya/Evaluation of the WHO cli 12407
ts in private hospitals in, Kenya/Opportunistic infections in 13244
ealth care centres in,Kenya, 1993 to 1997/Declines in 22190
IV/AIDS in the slums of /Community care for slum dwellers 22481
ng pregnancy women in, Kenya/Serodiscordance of HIV-1 23153
onegative prostitutes in,Kenya/A family study among relat 23354
onegative prostitutes in,Kenya/A family study among relat 23362
slums/AIDS orphans in slums/AIDS orphans in 422*/24219

ea and Chlamydia in an MV primary care population/Urine-based s